The nucleotide (nt) sequence of a Hepatitis C virus genome (HCV -N) which was derived from a single Japanese patient's serum in Nagasaki Prefecture has been determined by multiple clones coverning 22 overlapping regions of the HCV geneme. The sequenced region consisted of 9295 nt, including 248 nt of 5'-untranslated region (UTR) , a single large open reading frame (ORF) encoding a polyprotein of 3010 amino acids (aa) and a 17 nt of 3'-UTR. Phylogenetic analysis indicated that HCV-N belongs to II/1b genotype of group 1. Two other Nagasaki HCV strains (HCV-N1 and HCV-N2) were also sequenced in the E1 and N -terminus of the E2/NS1 regions. Two hypervariable regions (HVR 1 and HVR 2) were found in the N-terminus of E2/NS1 region among 3 Nagasaki strains and 7 other HCV strains with published sequences. Two well-conserved aa sequences were also identified among 10 HCV strains in the E1 and N -terminus of the E2/NS1 regions. The results will be useful for future under~tanding on the pathogenesis, virological diagnosis and development of vaccine for HCV.
INTRODUCTION
Hepatitis C virus (HCV) is the major cause of nonA -nonB (N ANB) hepatitis, and chronic infection with HCV has been linked to the development of liver cirrhosis and hepatocellular carcinoma (Plagemann, 1991) . Many entire and partial HCV sequence informations published so far have shown that HCV genome consisted of about 10 Kb single-stranded positive-sense RN A with 5'UTR, a single long ORF followed by 3'UTR. The viral genome organization resembles that of the flaviviruses and pestiviruses (Kato et at., 1990; Plagemann, 1991) .
Since Choo et al. (1989) Cloned the genome of an RN A virus from the plasma of a chimpanzee inoculated with plasma from patient with N ANB hepatitis and designated it as HCV, entire sequences have been reported for at least 15 In order to see the genetic variability of HCV in the Nagasaki area, HCV genome sequence in 2 more HCV patient sera in Nagasaki Prefecture (HCV-N1 and HCV -N2) were also analyzed similarly in the E1 and N -terminus of the E2/NS1 envelope glycoprotein regions. Two hypervariable regions have be found among these 3 Nagasaki HCV strains using the sequence diversity comparison with published sequence data of 7 HCV strains.
MATERIALS AND METHODS

RNA extraction from HCV patient serum
Serum samples were obtained from N ANB patients in Nagasaki Prefecture which were kindly provided by the Second Department of Internal Medicine of N agasaki University Hospital. These patients were confirmed to be infected with HCV by anti-ClOO HCV ELISA Kit (Ortho Diagnostic Systems, Tokyo, Japan) and HCV reverse-transcription polymerase chain reaction (RT -PCR) ,as published by Kurihara (1992) . One hundred microliters of HCV patient serum was mixed with 20 pI of 10% sodium dodecyl sulfate (SDS) and 80 pI of sterile distilled H 2 0 at room temperature for 5 min.
HCV RNA was extracted with phenol/chloroform and precipitated with 3 volumes of ice-cold absolute ethanol. After storage at -80°C for 1hr, HCV RNA was pelleted in an Eppendolf centrifuge with 15,000xg at 4°C for 30 min. The pellet was washed once in 70% ethanol, vacuum dried and dissolved in 100 pI sterile distilled water. RNA solution was stored at -80°C.
Selection and synthesis of oligonucleotide primers
Oligonucleotide primer sequences were selected based on the published sequence data , Takamizawa et al., 1991 and gene walking method. Oligonucleotide primers were synthesized by Applied Biosystems Model 392 DNA / RNA Synthesizer and confirmed for their purity by ion-exchange gel chromatography (Gen-pack; Waters).
RT-PCR
Ten microliters of RNA solution were added with 90 pI of RT -PCR mixture [l00 pmol of each primers, 0.2 mM deoxynucleoside triphosphate, 10 mM Tris (PH 8. 9), 1.5 mM MgCI 2 , 80 mM KCI, 0.5 mg of bovine serum albumin per ml, 0.1% sodium cholate, 0.1% Triton X -100, 10 U of reverse transcriptase (Life Science Inc.) and 2U of Tth DNA polymerase, a thermostable DNA polymerase (Toyobo Co.) J. The reaction mixture was covered by 2 drops of mineral oil and incubated for 10 min at 53°C for RT. PCR amplification (94°C for 60 sec, 53°C for 90 sec and 72°C for 120 sec by thermal cycler; Iwaki Co.) was started immediately after RT and repeated 35 times. cDNA product was subjected to agarose gel electrophoresis and visualized by ethidium bromide staining.
Cloning and sequencing of HCV cDNA product
The amplified HCV cDN A was excised from agarose gel, phosphorylated with T4 polynucleotide kinase (Nippon Gene Co.) and blunted with T4 DNA polymerase (Takara Co.). The modified cDNA fragment was ligated into Smal site of pUC19 and transformed into Escherichia ·coli JM 109 strain. The recombinant pUC19 carrying inserted cDNA fragment was purified with Wizard™ Minipreps DNA Purification System (U.S. A.). The cDNA fragment sequence was determined in both directions with sense and antisense primers by dideoxy chain termination method using both 35S radioisotope-labeling (DNA Sequencing Kit Version 2.0, U.S. A.) and fluorescent dye-labeled DNA sequencing system (373A DNA Sequencer, Applied Biosystems). To avoid sequence variability, 3 colones from each RT-PCR product were isolated independently for nucleotide sequence determination.
Analysis and homology comparison in nucleotide and deduced amino acid sequences were carried out for HCV -Nand 7 other HCV strains with published entire sequence, using a computer system with DN ASIS Mac Version 2.2, NEW CD2 system (Hitachi Software Engineering Co., Ltd, 1992).
RESULTS
The genome characterization of HCV-N
Multiple cDN A clones were isolated from altogether 22 overlapping regions which covered almost entire genome of HCV -N, except extreme 5' and 3' terminals ( Fig. 1) . For each of the overlapping region, 3 independent cDNA clones were isolated from the RT -PCR product and sequenced. The cleavage site of the polyprotein coded by the ORF of the HCV-N genome was assigned according to the publications by Okamoto et al. (1992b) and Honda et al. (1993) . Total length of the sequenced region of HCV -N consisted of 9295 nt and 3010 aa, respectively (Fig. 2) . The sequenced region can be divided into 248 nt in the 5'UTR, 9030 nt in a single ORF and 17 nt in the 3'UTR, respectvely. The ORF was considered to be translated into C (191 aa), E1 (192 aa), E2/NS1 (346 aa), NS2 (277 aa), NS3 (609 aa), NS4 (398 aa) and NS5 (997 aa) proteins. 
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Figure 2 respectively, The sequence homology of HCV -N also showed its closer relationship to HCV -1 than to HC-J6 and HC-J8 isolates ( to know the HCV sequence diversity of the envelope glycoprotein in local area of Nagasaki, 2 other HCV Nagasaki strains (HCV-N1 and HCV-N2) were also cloned and sequenced for the region of nt 623-1988, aa 126-580 (nt and aa base on the HCV -N number). Alignment comparison of deduced aa sequence among 3 Nagasaki strains and other 7 HCV strains with published sequences were shown in Fig. 4 . Two hypervariable regions (HVR) were discovered in the N -terminus of E2/NS1 region. HVR 1 (aa 384-411) was located directly downstream at the beginning of the E2/NS1, whereas HVR 2 (aa 475-480) was observed 64 aa downstream from the HVR 1. In the HVR 1 consisting of 28 aa, 10 aa residues were well-conserved among 3 Nagasaki strains. Whereas only 3 aa were conserved in this higher than among the different genotype or genogroup of HeV strains. Therefore, the 3 Nagasaki HCV strains may have been originated from the same ancestor.
In contrast, none of the· aa was conserved among 3 Nagasaki strains nor among a total 10 HeV strains in the HVR 2 which showed higher variability than the HVR 1. The reason why mutations occur so frequently in only limited regions such as HVR is not known (Tanaka et al., 1992) . The higher degree of divergence in HCV E2/NSI region might reflect the immune selection and suggest that this region cannot probably be an ideal target for future vaccine development.
Regarding the N -glycosylation sites in the El and N -terminus of the E2/NSI region, only 9 sites were conserved out of the 14 sites seen in HCV-N. Some of the glycosylation sites, therefore, would not be essential for the survival, transmission and maintenance of HeV in nature. On the other hand, 2 well-conserved aa sequences were found 'in the El and N -terminus of the E2/NSI regions among the 10 HeV strains compared. These conserved sequences may be better targets of vaccine development if they were related with protective immunity.
The nt sequence homology of HCV-N in the 5'UTR shows high conservation comparing with other 7 HeV isolates (nt > 91.5%) and was used as an ideal target for PCR amplification to detect HCV RNA (Okamoto et al., 1990 Simmonds et al., 1993a) . Therefore additional informations would be required to select optimal primer for peR diagnosis on HeV. The functional motifs of the putative encoded proteins of HCV (Plagemann et al., 1991; Tanaka et al., 1992) have also been found in HeV -N. There are consensus sequences of RNA helicase in the NS3 region: Gly-Ser-Gly-Lys-Ser-Thr (aa 1233-1238) and Gln-Arg -Arg-Gly-Arg-Thr-Gly-Arg (aa 1486-1493), while NS5 region possessed consensus sequence of RN A -dependent RNA polymerase: Gly-Asp-Asp (aa 2736-2738). The sequence heterogeneity in putative structural proteins and nostructural proteins of HeV provided significant evidence for genotype classification. The genetic informations of HCV -N genome obtained in this study will be useful in future understanding on the pathogenesis, diagnosis and development of vaccine for HCV.
